VCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's disease

MARCO ANTONIO CALZADO CANALEEDUARDO MUÑOZ BLANCOIRENE CANTARERO CARMONA2026-01-292026-01-29201610.1038/srep297892-s2.0-84979294063https://www.scopus.com/inward/record.uri?eid=2-s2.https://ucocris.uco.es/handle/123456789/27253MultidisciplinaryVCE-003.2, a novel cannabigerol derivative, enhances neuronal progenitor cell survival and alleviates symptomatology in murine models of Huntington's diseaseresearch article